Latest company announcements, clinical milestones, and platform updates.
Medfiniti signed a Master Service Agreement with United Digestive — a premier GI practice management network with 81+ clinic locations and 129 specialized physicians across the Southeastern U.S. Additionally, the USPI rollout has begun and HCA has updated its Master Agreement for Gen 2 device deployment, advancing HemWell MD across major national healthcare networks.
USPI Coding News edition published with official CPT code guidance for the Hemwellectomy procedure. Medicare 2026 reimbursement rate established at $1,432.51 for CPT codes 46945 and 46946, standardizing payment across ASC networks nationwide.
HemWell Gen 2 devices performed a record 650 procedures in April across 51 active centers, with 8 centers just beginning operations, bringing the year-to-date total to 2,101 since January 2026.
HemWell MD Gen 2 rollout continues across all 51 active clinical centers nationwide. Gen 1 replacement underway while maintaining seamless patient care continuity.
HemWell MD platform surpasses 40,000+ cumulative procedures across 44 active clinical centers at the start of Gen 2 rollout, establishing the foundation for continued platform expansion.
Gen 2 deployment supports expansion into additional states with new physician partnerships and center rollouts announced for Q1–Q2 2026.
Medfiniti launches HemWell MD Gen 2 with enhanced device architecture, improved connectivity, and strengthened platform infrastructure for future growth.
Subscribe to receive the latest Medfiniti news and platform updates.